Obvia’s Vision is to become the leading company in ROS-scavenging medicine and transform the prevention and treatment of acute and chronic diseases with high unmet need and significant healthcare burden.
Obvia’s Mission
Obvia’s Mission is to develop ROS-targeted therapies that deliver meaningful impact for patients worldwide and create lasting value through innovation and disciplined execution.
Our Team
-
Sabine Goesch, Msc, MBA
Board Member
Chief Executive Officer & CFO
Co-Owner
-
William Fahl, PhD
Board Chairman
Chief Scientific Officer
Co-Founder
-
Peder Andersen, MD
Board Member
Chief Medical Officer
Chief Operations Officer
-
Harri Jarvelainen, DVM, PhD, DABT, ERT
Toxicology
Our Partners
Indication
Radiation
Radiation
Awarded Grants
Mitigation of Radiation-Induced Immune Dysfunction by PrC-210 Treatment.
Synergistic Efficacy of PrC-210 and G-CSF in Conferred Radiation Survival Benefits
Agency
NIH, AFFRI
NIH, CMCRC
$200k
2022 - 2024
Neurodegeneration
Progressing PrC-210 to clinical treatment for the prevention of neurodegenerative diseases after radiation
DOD
$1.1 Mio.
2022 - 2025
Transplantation
Novel Application of PrC-210 aminothiol free-radical scavenger for the protection of vascularized allotransplants
DOD
$1.0 Mio.
2021 - 2025
DOD
Transplantation
PrC-210 for Rapid Limb Stabilization and Protection from Prolonged Ischemia-Reperfusion Injury
$750k
2020 - 2023
DOD
Funding
$2.5 Mio.
Transplantation
Grant Title
Increasing immune tolerance in VCAs with innovative PrC-210 and identifying new corresponding peripheral biomarker for acute and chronic VCA rejection.
$200k
Timeline
2021 - 2027
2022 - 2026
The Spirit of Discovery
Innovation
We pursue groundbreaking science through relentless curiosity and creativity.
We push the boundaries of biotechnology with a spirit of discovery, always exploring new ideas and technologies. Innovation thrives in our culture because people are free to experiment without fear of failure – mistakes are viewed as learning opportunities that spark insight and continuous improvement. By embracing curiosity and forward thinking, we turn novel concepts into transformative solutions.
Courage
We have the courage to take risks, learn from failures, and persevere with determination.
Achieving breakthrough innovation requires bold action and resilience. We empower our team to challenge the status quo and speak up with ideas, knowing that only by venturing beyond our comfort zone do we make great strides. When obstacles arise, we respond with grit and adaptability. The unwavering courage – to try, to fail, and to try again – fuels our passion and energy to achieve more than we thought possible.
Teamwork
We succeed as one unified team, through trust, respect, and collaboration.
We believe the greatest discoveries happen together. Every individual’s talent is valued, and we combine our strengths to reach ambitious goals. We foster an environment of trust, openness, and mutual support, where diverse perspectives are encourages and everyone’s contributions matter. By inspiring and relying on each other, we create an inclusive team that celebrates successes together and learns from challenges together, driving us all to excel.
Excellence
We are driven to deliver high-quality results and make a meaningful impact.
In our pursuit of growth and scientific advancement, we hold ourselves to the highest standards of quality and integrity. Each of us takes ownership and accountability for our objective, pushing for executional excellence in research and development. With ambition and focus, we translate innovative ideas into tangible outcomes – life-changing therapies and scientific breakthroughs. We continuously seek to improve, ensuring that our passion for excellence results in real-world benefits for patients, partners, and the company.